Fresenius | FRE
Stock Price
33.31
Daily Change
0.52 1.59%
Monthly
-0.36%
Yearly
19.22%
Q4 Forecast
35.24


Peers Price Chg Day Year Date
Akzo Nobel 55.88 0.26 0.47% -19.39% Nov/22
Alcon AG 76.68 0.78 1.03% 18.37% Nov/22
AstraZeneca 10,474.00 412.00 4.09% 2.95% Nov/22
BASF 42.58 0.47 1.12% -2.81% Nov/22
Bayer 19.80 0.28 1.46% -39.90% Nov/22
Beiersdorf 122.90 1.75 1.44% -3.91% Nov/22
DaVita Healthcare Partners 165.41 0.91 0.55% 66.64% Nov/22
Essilor 235.30 2.90 1.25% 32.38% Nov/22
E.ON 12.04 0.42 3.57% 3.04% Nov/22
Fresenius Medical Care 42.25 0.81 1.95% 16.49% Nov/22
Fresenius 33.31 0.52 1.59% 19.22% Nov/22
Getinge 168.00 2.65 1.60% -24.87% Nov/22
Givaudan 3,933.00 14.00 0.36% 21.95% Nov/22
GN Store Nord 134.95 3.90 2.98% -9.79% Nov/22
GRIFOLS 10.60 0.20 1.92% -17.61% Nov/22
GlaxoSmithKline 1,342.00 32.50 2.48% -5.56% Nov/22
Hikma Pharmaceutical 1,950.00 78.00 4.17% 11.24% Nov/22
Lonza 521.40 -0.20 -0.04% 48.25% Nov/22
Merck 141.75 3.45 2.49% -11.93% Nov/22
Novartis 93.68 2.12 2.32% 8.61% Nov/22
Philips 25.22 0.19 0.76% 28.83% Nov/22
Roche Holding 254.30 3.20 1.27% 6.69% Nov/22
RWE 31.01 0.24 0.78% -18.84% Nov/22
Sanofi 93.17 2.30 2.53% 8.04% Nov/22
Smith & Nephew 986.80 10.80 1.11% -4.38% Nov/22
Demant 266.20 8.20 3.18% -4.55% Nov/22

Indexes Price Day Year Date
DE40 19323 176.42 0.92% 20.81% Nov/22
EU50 4790 34.12 0.72% 9.83% Nov/22
EU600 508 5.93 1.18% 10.91% Nov/22

Fresenius traded at 33.31 this Friday November 22nd, increasing 0.52 or 1.59 percent since the previous trading session. Looking back, over the last four weeks, Fresenius gained 0.36 percent. Over the last 12 months, its price rose by 19.22 percent. Looking ahead, we forecast Fresenius to be priced at 35.24 by the end of this quarter and at 34.02 in one year, according to Trading Economics global macro models projections and analysts expectations.

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.